Healthcare (SH:603313)2020-04-28 16:00Financial Performance - Operating revenue rose by 34.43% to CNY 1,058,123,911.23 year-on-year[11] - Net profit attributable to shareholders increased by 6.54% to CNY 80,280,832.94 compared to the same period last year[11] - The net profit after deducting non-recurring gains and losses surged by 72.62% to CNY 84,461,050.11 year-on-year[11] - Total operating revenue for Q1 2020 reached ¥1,058,123,911.23, a 34.4% increase from ¥787,122,185.19 in Q1 2019[38] - Net profit for Q1 2020 was ¥89,614,051.96, representing a 16.5% increase compared to ¥76,984,346.64 in Q1 2019[42] - The company reported a total comprehensive income of ¥72,319,658.75 for Q1 2020, compared to ¥75,694,480.89 in Q1 2019[44] Assets and Liabilities - Total assets increased by 18.46% to CNY 5,472,360,023.40 compared to the end of the previous year[11] - Total liabilities increased to CNY 2,897,017,406.54, up from CNY 2,215,938,822.91, representing a growth of approximately 30.7% year-over-year[31] - The company's total equity attributable to shareholders rose to CNY 2,481,751,345.70 from CNY 2,334,071,079.34, reflecting an increase of approximately 6.3%[31] - The total current liabilities amounted to CNY 2,547,558,360.37, up from CNY 2,018,500,511.91, which is an increase of about 26.2%[36] - The total assets of the company reached ¥4,400,065,310.58 in Q1 2020, an increase from ¥4,024,213,560.89 in Q1 2019[38] - The total liabilities reached ¥1,950,609,954.05 in Q1 2020, compared to ¥1,698,637,156.24 in Q1 2019, reflecting a growth of 14.8%[38] Cash Flow - Net cash flow from operating activities decreased by 31.92% to CNY 82,142,224.95 compared to the previous year[11] - The net cash flow from investing activities was negative CNY 511,086,520.98, mainly due to payments for investments in Mor[21] - The company reported a net cash flow of CNY 399,244,175.92 from financing activities, primarily due to increased bank borrowings[21] - The net cash flow from operating activities for Q1 2020 was approximately ¥82.14 million, down from ¥120.66 million in Q1 2019, a decrease of about 32%[50] - The net cash flow from investing activities in Q1 2020 was approximately -¥511.09 million, compared to -¥95.68 million in Q1 2019, indicating a significant increase in cash outflow[50] - The net cash flow from financing activities in Q1 2020 was approximately ¥399.24 million, a substantial increase from ¥29.76 thousand in Q1 2019[52] Shareholder Information - The total number of shareholders at the end of the reporting period was 17,114[14] - The largest shareholder, Ni Zhanggen, holds 54.05% of the shares, amounting to 184,401,319 shares[18] Inventory and Goodwill - Inventory increased by 39.41% to CNY 1,034,099,977.90, primarily due to the inventory from the newly acquired company, Mor, in the U.S.[20] - Goodwill surged by 305.08% to CNY 368,893,243.32, mainly resulting from the acquisition of Mor in the U.S.[20] Expenses - Total operating costs for Q1 2020 were ¥944,231,527.73, up 31.3% from ¥719,324,944.67 in Q1 2019[38] - Sales expenses increased to ¥187,014,408.68 in Q1 2020, compared to ¥90,194,966.31 in Q1 2019, indicating a significant rise of 106.8%[38] - Research and development expenses for Q1 2020 were ¥18,478,603.08, slightly down from ¥19,179,302.91 in Q1 2019[38] Equity and Retained Earnings - The company's retained earnings increased to CNY 808,918,566.34 from CNY 728,637,733.40, a growth of approximately 11%[31] - The company's equity totaled ¥2,403,836,528.19, with total shareholder equity at ¥2,334,071,079.34, indicating a solid equity position[59]